Joseph David Zibrak, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Malpractice | 1 | 2019 | 554 | 0.480 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2014 | 898 | 0.260 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 2 | 2020 | 499 | 0.220 |
Why?
|
| Physicians | 1 | 2019 | 4586 | 0.190 |
Why?
|
| Carbon Monoxide Poisoning | 1 | 1998 | 66 | 0.150 |
Why?
|
| Respiratory Function Tests | 3 | 1993 | 1685 | 0.150 |
Why?
|
| Respiratory Therapy Department, Hospital | 2 | 1987 | 2 | 0.150 |
Why?
|
| Hospital Departments | 2 | 1987 | 136 | 0.140 |
Why?
|
| Tracheal Diseases | 1 | 1996 | 115 | 0.130 |
Why?
|
| Bronchial Diseases | 1 | 1996 | 151 | 0.130 |
Why?
|
| Thoracotomy | 1 | 1996 | 362 | 0.120 |
Why?
|
| Oxygen Inhalation Therapy | 2 | 1987 | 403 | 0.110 |
Why?
|
| Pyridones | 1 | 2017 | 787 | 0.100 |
Why?
|
| Thoracic Vertebrae | 1 | 1996 | 597 | 0.100 |
Why?
|
| Video Recording | 1 | 1996 | 954 | 0.090 |
Why?
|
| Respiratory Therapy | 2 | 1993 | 127 | 0.090 |
Why?
|
| Scoliosis | 1 | 1996 | 731 | 0.090 |
Why?
|
| Early Diagnosis | 1 | 2014 | 1181 | 0.080 |
Why?
|
| Gastric Dilatation | 1 | 1988 | 4 | 0.080 |
Why?
|
| Lung | 7 | 2017 | 9982 | 0.080 |
Why?
|
| Lung Diseases, Obstructive | 1 | 1988 | 308 | 0.070 |
Why?
|
| Pneumonia, Aspiration | 1 | 1988 | 146 | 0.070 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 2282 | 0.070 |
Why?
|
| Critical Care | 1 | 2019 | 2697 | 0.070 |
Why?
|
| Respiratory Tract Neoplasms | 1 | 1986 | 57 | 0.070 |
Why?
|
| Dyspnea | 1 | 2014 | 1352 | 0.070 |
Why?
|
| Gastric Emptying | 1 | 1988 | 243 | 0.070 |
Why?
|
| Utilization Review | 1 | 1987 | 383 | 0.070 |
Why?
|
| Pulmonary Alveoli | 2 | 1987 | 652 | 0.060 |
Why?
|
| Preoperative Care | 2 | 1993 | 2256 | 0.060 |
Why?
|
| Health Services Misuse | 1 | 1986 | 245 | 0.060 |
Why?
|
| Sarcoma, Kaposi | 2 | 1988 | 376 | 0.060 |
Why?
|
| Electroconvulsive Therapy | 1 | 1988 | 500 | 0.050 |
Why?
|
| Lung Abscess | 1 | 2002 | 41 | 0.050 |
Why?
|
| Postoperative Complications | 3 | 1996 | 15672 | 0.050 |
Why?
|
| Surgical Procedures, Operative | 1 | 1993 | 1914 | 0.050 |
Why?
|
| Health Services | 1 | 1986 | 754 | 0.050 |
Why?
|
| Lung Diseases | 1 | 1990 | 1915 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1996 | 8929 | 0.040 |
Why?
|
| Vital Capacity | 2 | 2020 | 964 | 0.040 |
Why?
|
| Primary Health Care | 1 | 2014 | 4639 | 0.040 |
Why?
|
| Hyperbaric Oxygenation | 1 | 1998 | 166 | 0.040 |
Why?
|
| Hospital Bed Capacity, 300 to 499 | 2 | 1987 | 57 | 0.040 |
Why?
|
| Respiration, Artificial | 1 | 1988 | 2616 | 0.040 |
Why?
|
| Spirometry | 1 | 2020 | 923 | 0.040 |
Why?
|
| Disease Progression | 3 | 2022 | 13479 | 0.040 |
Why?
|
| Bronchography | 1 | 1996 | 75 | 0.030 |
Why?
|
| Humans | 23 | 2022 | 759255 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 2002 | 857 | 0.030 |
Why?
|
| Depressive Disorder | 1 | 1988 | 3728 | 0.030 |
Why?
|
| Lung Volume Measurements | 1 | 1996 | 376 | 0.030 |
Why?
|
| Database Management Systems | 1 | 1997 | 258 | 0.030 |
Why?
|
| Acquired Immunodeficiency Syndrome | 3 | 1988 | 2198 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2009 | 3207 | 0.030 |
Why?
|
| Hospital Information Systems | 1 | 1997 | 396 | 0.030 |
Why?
|
| Cost Control | 2 | 1986 | 630 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1996 | 20461 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2020 | 1783 | 0.030 |
Why?
|
| Consensus | 1 | 2022 | 3095 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 15815 | 0.020 |
Why?
|
| Pneumonia, Pneumocystis | 3 | 1988 | 245 | 0.020 |
Why?
|
| Trachea | 1 | 1996 | 1082 | 0.020 |
Why?
|
| Bronchial Spasm | 1 | 1988 | 72 | 0.020 |
Why?
|
| Sulfamethizole | 1 | 1987 | 3 | 0.020 |
Why?
|
| Sulfathiazoles | 1 | 1987 | 3 | 0.020 |
Why?
|
| Trimethoprim | 1 | 1987 | 85 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2017 | 2979 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 6813 | 0.020 |
Why?
|
| Exudates and Transudates | 1 | 1987 | 175 | 0.020 |
Why?
|
| Blue Cross Blue Shield Insurance Plans | 1 | 1987 | 93 | 0.020 |
Why?
|
| Myasthenia Gravis | 1 | 1990 | 213 | 0.020 |
Why?
|
| Opportunistic Infections | 2 | 1987 | 377 | 0.020 |
Why?
|
| Medication Adherence | 1 | 2017 | 2161 | 0.020 |
Why?
|
| Blood Gas Analysis | 1 | 1986 | 378 | 0.020 |
Why?
|
| Hydroxylysine | 1 | 1985 | 5 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 1990 | 1375 | 0.020 |
Why?
|
| Chemical Fractionation | 1 | 1985 | 62 | 0.020 |
Why?
|
| Diagnosis-Related Groups | 1 | 1986 | 450 | 0.020 |
Why?
|
| Microbial Collagenase | 1 | 1985 | 113 | 0.010 |
Why?
|
| Risk Factors | 4 | 2017 | 74167 | 0.010 |
Why?
|
| Random Allocation | 1 | 1988 | 2393 | 0.010 |
Why?
|
| Abdomen | 1 | 1990 | 1121 | 0.010 |
Why?
|
| Boston | 2 | 1987 | 9274 | 0.010 |
Why?
|
| Rats, Inbred Strains | 1 | 1985 | 2094 | 0.010 |
Why?
|
| Elastin | 1 | 1985 | 300 | 0.010 |
Why?
|
| Intensive Care Units | 1 | 1997 | 3731 | 0.010 |
Why?
|
| Radiography | 2 | 2002 | 6964 | 0.010 |
Why?
|
| Bacteria, Aerobic | 1 | 2002 | 25 | 0.010 |
Why?
|
| Bacteria, Anaerobic | 1 | 2002 | 70 | 0.010 |
Why?
|
| Smoking | 2 | 2002 | 9066 | 0.010 |
Why?
|
| ROC Curve | 1 | 2009 | 3570 | 0.010 |
Why?
|
| Respiratory Insufficiency | 1 | 1990 | 1225 | 0.010 |
Why?
|
| Bronchoscopy | 1 | 1986 | 902 | 0.010 |
Why?
|
| Postoperative Care | 1 | 1986 | 1478 | 0.010 |
Why?
|
| Male | 8 | 2002 | 358719 | 0.010 |
Why?
|
| Time Factors | 2 | 2017 | 40109 | 0.010 |
Why?
|
| Local Area Networks | 1 | 1997 | 11 | 0.010 |
Why?
|
| Middle Aged | 6 | 2009 | 219653 | 0.010 |
Why?
|
| Data Collection | 1 | 1986 | 3317 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2002 | 3468 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 1 | 1988 | 3152 | 0.010 |
Why?
|
| Cardiac Surgical Procedures | 1 | 1990 | 3617 | 0.010 |
Why?
|
| Female | 5 | 2002 | 390240 | 0.010 |
Why?
|
| Aged | 3 | 2009 | 168617 | 0.010 |
Why?
|
| Massachusetts | 1 | 1986 | 8788 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 15264 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 1988 | 8055 | 0.010 |
Why?
|
| Length of Stay | 1 | 1986 | 6452 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 1996 | 58867 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1986 | 12964 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 1986 | 4359 | 0.010 |
Why?
|
| Skin | 1 | 1985 | 4467 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 64879 | 0.010 |
Why?
|
| Medical Records Systems, Computerized | 1 | 1997 | 1192 | 0.010 |
Why?
|
| Forced Expiratory Flow Rates | 1 | 1988 | 75 | 0.010 |
Why?
|
| Rats | 1 | 1985 | 23694 | 0.000 |
Why?
|
| Child | 1 | 1996 | 79623 | 0.000 |
Why?
|
| Adolescent | 1 | 1996 | 87560 | 0.000 |
Why?
|
| Acetylglucosaminidase | 1 | 1987 | 67 | 0.000 |
Why?
|
| Peroxidases | 1 | 1987 | 135 | 0.000 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1987 | 412 | 0.000 |
Why?
|
| Myocardial Infarction | 1 | 1986 | 11888 | 0.000 |
Why?
|
| Adult | 4 | 2002 | 219390 | 0.000 |
Why?
|
| Cricetinae | 1 | 1987 | 2427 | 0.000 |
Why?
|
| Phospholipids | 1 | 1987 | 788 | 0.000 |
Why?
|
| Forced Expiratory Volume | 1 | 1988 | 1807 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1987 | 54204 | 0.000 |
Why?
|
| Isoenzymes | 1 | 1987 | 1690 | 0.000 |
Why?
|
| Cytoplasm | 1 | 1987 | 1521 | 0.000 |
Why?
|
| Drug Combinations | 1 | 1987 | 2023 | 0.000 |
Why?
|
| Fibroblasts | 1 | 1987 | 4084 | 0.000 |
Why?
|
| Animals | 2 | 1987 | 167838 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2002 | 80121 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1987 | 18968 | 0.000 |
Why?
|